![Paul Y. Song](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Y. Song
Director Ejecutivo en NKGen Biotech, Inc. .
Fortuna: 284 409 $ al 31/05/2024
Perfil
Dr. Paul Song is a Chairman & Chief Executive Officer at NKGen Biotech, Inc. and a Chairman & Chief Executive Officer at NKGen Operating Biotech, Inc. He is on the Board of Directors at PeproMene Bio, Inc., Gideons Promise, Inc. and Mercy Corps.
Dr. Song was previously employed as a Chief Executive Officer & Director by Fuse Biotherapeutics, Inc. and a Chief Medical Officer by NKMAX Co., Ltd.
(South korea).
He received his undergraduate degree from The University of Chicago and a doctorate degree from George Washington University School of Medicine & Health.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
0.68% | 29/04/2024 | 170 305 ( 0.68% ) | 284 409 $ | 31/05/2024 |
Cargos activos de Paul Y. Song
Empresas | Cargo | Inicio |
---|---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Director Ejecutivo | 10/01/2023 |
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Director/Miembro de la Junta | 01/03/2022 |
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Director/Miembro de la Junta | - |
Gideons Promise, Inc. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Paul Y. Song.
Empresas | Cargo | Fin |
---|---|---|
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Fundador | 01/01/2023 |
NKMAX CO., LTD. | Director Técnico/Científico/I+D | 01/01/2021 |
Formación de Paul Y. Song.
George Washington University School of Medicine & Health | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NKMAX CO., LTD. | Health Technology |
Empresas privadas | 5 |
---|---|
NKGen Biotech, Inc.
![]() NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
![]() Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
PeproMene Bio, Inc.
![]() PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
Mercy Corps
![]() Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
Gideons Promise, Inc. |
- Bolsa de valores
- Insiders
- Paul Y. Song